i-Base home
Search Menu
  • Home
  • HTB
  • IAS 13th Kigali 2025

IAS 13th Kigali 2025

13th IAS Conference on HIV Science (IAS 2025): Introduction and early reports

21 July 2025. Related: Conference reports, Activism & advocacy.

Once-weekly oral ART with ulonivirine plus islatravir: 24-week phase 2 results

20 July 2025. Related: Conference reports, Antiretrovirals.

IAS 2025: Reduced dosing could be a safe option for adults: crisis response to ART stock-outs

17 July 2025. Related: Conference reports, Treatment strategies.

IAS 2025: 5-on 2-off dosing is inferior to continuous ART in BREATHER Plus – but no difference in clinical outcomes

17 July 2025. Related: Conference reports, Treatment strategies.

IAS 2025: Long-acting CAB/RPV in people with suboptimal adherence: IMPALA study results at 48 weeks

17 July 2025. Related: Conference reports, Antiretrovirals, Drug resistance.

!AS 2025: Once-monthly oral PrEP using MK-8527: the drug that will stop HIV

17 July 2025. Related: Conference reports, Treatment strategies.

IAS 2025: “We will not be erased” – a community Call to Action

15 July 2025. Related: Conference reports, Treatment access, Activism & advocacy.

IAS 2025: HIV care is political: early focus on the funding crisis

12 July 2025. Related: Conference reports, Treatment access.

IAS 2025: HIV cure research at IAS 2025

12 July 2025. Related: Conference reports.

IAS 2025: Kigali Call to Action: sign-on to global leaders

1 July 2025. Related: Conference reports.

  • HTB RSS

Early access

  • Positive opinion for lenacapavir indication as PrEP in the EU 25 July 2025
  • AIDS quilts at the Tate: reflection and also anger 8 July 2025
  • US government has altered more than 100 scientific databases since 20 January 5 July 2025
  • All early access reports

Current issues

  • July 2025
  • June 2025
  • May 2025
  • Back issues

Special report

  • AIDS quilts at the Tate: reflection and also anger 8 July 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook